Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Resources

OBAT Clinical Tools and Forms

Clinic Visit Documentation

Buprenorphine Initiation Note
Download file

Initial Screening Note Template
Download file

OBAT Nurse Intake Form
Download file

OBAT Nursing Follow-up Note Template
Download file

Clinical Algorithms

Buprenorphine Quick Start
Pathways for starting patients on buprenorphine with various levels of opioid dependence: those not currently opioid dependent, those opioid dependent in active withdrawal, and those at both high and low risk for precipitated withdrawal. This is not meant to replace clinical decision-making.
Download file

Initiation of Monthly Injectable Buprenorphine
Guidance for starting a patient on monthly injectable buprenorphine, including required preparation and injection day planning. This is not meant to replace clinical decision-making.
Download file

Naltrexone Initiation for Alcohol Use Disorder
Guidance for starting a patient on long-acting injectable naltrexone (Vivitrol) for the treatment of alcohol use disorder. This is not meant to replace clinical decision-making.
Download file

Naltrexone Initiation for Opioid Use Disorder
Guidance for starting a patient on long-acting injectable naltrexone (Vivitrol) for the treatment of opioid use disorder. Includes strategies for managing opioid withdrawal during washout period and avoiding precipitated withdrawal. This is not meant to replace clinical decision-making.
Download file

Pain Management While on Buprenorphine for Opioid Use Disorder
Guidance for managing acute and chronic pain in patients already on buprenorphine for opioid use disorder. This is not meant to replace clinical decision-making.
Download file

Clinical Tool

Considerations for Medication for Addiction Treatment in HCV+ Patients
Download file

Considerations for Medication for Addiction Treatment in Patients with HIV
Download file

Perioperative Management
This document gives management guidelines for patients maintained on buprenorphine who are scheduled for surgery or other procedures.
Download file

Consents and Treatment Agreements

Consent for Release of Information (CFR 42)

English
Spanish

Consent for Treatment with Buprenorphine-Naloxone in Pregnancy
Download file

Consent for Treatment with Disulfiram

English
Haitian Creole
Portuguese
Spanish

Consent for Treatment with Injectable Buprenorphine

English
Haitian Creole
Portuguese
Spanish

Consent for Treatment with Naltrexone

English
Haitian Creole
Portuguese
Spanish

Sample OBAT Treatment Agreement

English
Haitian Creole
Portuguese
Spanish

Transmucosal Buprenorphine Consent Form

English
Haitian Creole
Portuguese
Spanish

General Clinical Tools

Buprenorphine Start Guide for Patients: A Guide for Patients Beginning Buprenorphine
This is a modified version of NIDA's guidance on conducting a buprenorphine community induction that can be given out to patients.

English
Spanish

Checklist Prior to Buprenorphine-Naloxone Initiation
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 27-28.
Visit webpage

Checklist Prior to Monthly Buprenorphine Injection
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 45-46.
Visit webpage

Checklist Prior to Naltrexone Initiation
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 55-56.
Visit webpage

COWS Scale Opioid Withdrawal Record Induction Form
Download file

DSM-5 Checklist of Diagnostic Criteria: Opioid Use Disorder
Download file

Novel Naloxone Distribution Strategies
This document outlines potential strategies to increase patient access to nasal naloxone by serving as a guide for administrators, healthcare providers, and non-medical providers attempting to create reimbursable streams for naloxone.
Download file

Patient Medication Guide for Injectable Buprenorphine
Visit webpage

Patient Medication Guide for Injectable Naltrexone (Vivitrol)
Visit webpage

Pharmacotherapy for Alcohol Use Disorder

Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update | Effective Health Care Program | AHQR

Pharmacotherapy for Opioid Use Disorder
Please visit SAMHSA's TIP 63: Medications for Opioid Use Disorder Executive Summary page ES-6.
Visit webpage

Transfer Guidelines for Methadone to Buprenorphine or Buprenorphine to Naltrexone Transition
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 33-36.
Visit webpage

Words Matter
A one-page handout with words to use and avoid when talking about addiction.

English
Spanish

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2023 Boston Medical Center. All rights reserved. Site by Root802.